Rapid changes of ion, intensity, beam line, and output energy between two modes have been achieved.
Introduction
The Bevalac complex is comprised of the Bevatron and its experimental area, the SuperHILAC and its experimental area, and the tandem combination of the two accelerators (the Bevalac). The SuperHILAC is a linear accelerator with output energies from 1.2 to 8.5 MeV/n, at a pulse rate of 36 per second. For most applications, 34 of the 36 pulses are used by SuperHILAC experimenters, and two pulses per second are used for injection into the Bevatron. Source switching is done at the 36/second rate, so that users have independent choice of ions.
In one example, the Bevatron will use neon at 8.5 MeV/n and the SuperHILAC will use xenon at 5 MeV/n compatibly.
The Bevatron is a weak-focusing positive-ion synchrotron with output energies from 20 MeV/n to 2000 MeV/n, (protons from .35 to 4.9 GeV) depending on the ion species and research requirements. Its pulse rate is 10 to 15 per minute, depending on the maximum energy being delivered. Table 1 Bevalac research programs are divided into two major categories, nuclear science and biology & medicine. Our nuclear science program encompasses ions spanning the periodic chart at particle energiesfrom low to relativistic. Biomedical studies include heavy-ion radiotherapy four days per week and biology in support of the therapy as well as independent radiobiological studies. These independent studies are generally treated the same as the nuclear science programs; blocks of time are reserved for the individual experiments at the ion and energy of choice.
Radiotherapy, however, involves daily treatment of about 10 patients per day for four days per week with neon ions at an energy of 670 MeV/n. Each patient requires about 25 minutes of setup time per day at the end of a beam line, and about 5 minutes of actual beam time, so the total time per patient is about 30 minutes, of which 25 do not require beam.
Heavy ion radiotherapy is unique to the Bevalac and is an extremely valuable project that receives high priority. We have found, however, that the nuclear science program has been at a disadvantage because of the rigid clinical requirements imposed on the Bevalac, to wit, treatments every week of operation, four days per week, with neon at 670 MeV/n. These treatments extend for about 8 hours per day. The other 16 hours per day, and the weekends, are generally devoted to the nuclear science program. Major interruptions occur to the physics program because it must start and stop every treatment day. Not only must it start and stop, the transients of accelerator tuneups reduce the 16 hours to an effective 8-10 hours of target time. Such a set of programs requires rapid changes of ion, energy, and beam line to maintain efficiency of operation for all users.
The Challenge Ideally, the heavy-ion radiotherapy program should be transparent to the nuclear science program; most of our operating time should be spent in the non-therapy mode, transferring to the therapy mode only when the beam is actually needed for treatment.
In order to establish this rapid switch, a way had to be found to reduce the transient effects of program changes. The specific goals to be met include fast, reproducible changes of 1) target area/beam line, 2) energy, and 3) ion.
Effecting these changes in one minute or less constitutes realization of the goal.
Beam-line switching with no change of ion or energy was developed first and has been in regular use for several years. However, the demand for 670 MeV/n neon is not large and delivery of it to another beam line is often not useful to the physicist for more than initial tuneup and equipment checks. A different energy, or a different ion, or both, is necessary, if the interpatient time is to be used effectively. 
Conclusion
The challenge we have met is changing all of the Bevalac complex operating parameters, including ion species, delivery point (or target area), energy, and intensity between two arbitrarily chosen sets that correspond to the needs of two separate experiments in the period of less than one minute. In programmatic terms we have achieved what we call "transparency" of the radiotherapy program. It now becomes a series of minor interruptions to our nuclear science program, mostly invisible and certainly not burdensome. As an added benefit of achieving transparency, we now have the capability and the opportunity to fast-switch between selected nuclear science beam lines, allowing preliminary tuneup of one experiment from time to time at minimum disruption to the operating experiment. Major contributors to this record are the capabilities for storage of complete parameter tables in the control computer, the availability of multiple ion sources operating virtually simultaneously, favorable disposition of the various power supply components to quick changes, and the ingenuity of the scientists, engineers, operators, and technicians who developed the concepts, the hardware, and the software necessary to this project.
